TCR-dependent and TCR-independent in-vitro T cell activation generate distinct functional, metabolic, and cytokine programs: Protein kinase C signalling augments anti-CD3+anti-CD28 responses

IntroductionT cell activation is central to the adaptive immune response. In vitro studies on T cell activation often utilize two distinct approaches: first, engaging T cell receptors (TCR) using plate-bound CD3 together with soluble CD28 (TCR-dependent). Second, triggering intracellular signalling cascades using phorbol 12-myristate 13-acetate (PMA) and Ionomycin or P+I (TCR-independent). Both methods are widely used; however, a systematic comparison of the activation methods across a range of stimulation strengths to evaluate their effects on T cell function and metabolism has not been investigated in great detail. In this study, we compared the consequences of engaging T cells using TCR-dependent and TCR-independent activation pathways across varying signal strengths. MethodsT cells from BALB/c mice were isolated and activated under four conditions: CD3, CD3+CD28, PMA with low Ionomycin (P+IL) and PMA with high Ionomycin (P+IH). We studied differences with respect to several parameters: morphology, flow analysis, metabolic activities, cytokines. The roles of Protein kinase C (PKC) and Ca{superscript 2} pathways were addressed by supplementing CD3+CD28 cultures with different doses of exogenous PMA or Ionomycin. ResultsP+I activation outperformed the CD3+CD28 activation system across most readouts by displaying enhanced blasts, higher cycling, greater glucose uptake, increased lactate and ROS production, together with higher upregulation of CD25 and CD44 activation markers. P+IH activation dampened several responses including CD69 expression. CD4 co-receptor was downregulated greatly with P+I activation but not CD3+CD28. Most cytokines followed signal strength comparably between both systems; however, differences were observed with others: P+I stimulation favoured IL-6 and IL-12 induction whereas CD3+CD28 activation preferentially induced CCL2 and IL-1{beta}. Importantly, PKC activity was substantially lower upon CD3+CD28 stimulation and the addition of PMA, but not Ionomycin, to CD3+CD28 cultures enhanced proliferation, metabolism and expression of activation markers. DiscussionTCR-dependent and TCR-independent T cell activation models have clear functional and metabolic differences. The observation that PKC signalling can boost T cell activation with CD3+CD28 is likely to be significant and may have translational implications such as CAR-T cell anti-tumor therapy where CD3+CD28 stimulation is widely used. The implications of our findings with regard to augmenting T cell mediated immunotherapies are discussed.